COVID Healthcare Marketing Questions: Pause, Pivot, or Push Forward

COVID Healthcare Marketing Webinar COVID-19 has changed the healthcare industry quicker in the last two weeks than in the last 50 years. With medical practices temporarily shutting down and elective procedures put on hold, what should healthcare networks and healthcare specialists do with their marketing campaigns‘ strategies? Stewart Gandolf, CEO, Healthcare Success Aaron Clifford, SVP …

COVID Healthcare Marketing Questions: Pause, Pivot, or Push Forward Read More »

Moving remote: the post-pandemic clinical trial

The restrictions on movement and normal interaction owing to COVID-19 pose a distinct challenge to the traditional clinical trial model, as patients, investigators and clinical staff are either confined to their homes or seeking to avoid healthcare settings.    Those running clinical trials over the past weeks have had to adapt rapidly by fast-tracking digital …

Moving remote: the post-pandemic clinical trial Read More »

How to Treat Endometriosis with Diet

“Endometriosis is a major cause of disability and compromised quality of life in women and teenage girls.” It “is a chronic disease which is under-diagnosed, under-reported, and under-researched…[and for patients, it] can be a nightmare of misinformation, myths, taboos, lack of diagnosis, and problematic hit-and-miss treatments overlaid by a painful, chronic, stubborn disease.” Pain is …

How to Treat Endometriosis with Diet Read More »

Research Headlines – Collecting the world’s viruses, empowering urgent research

Ebola, Zika, MERS, COVID-19? An EU-funded collection of mammalian viruses is supporting researchers around the globe in their efforts to shed new light on old and emerging illnesses and advance their treatment and control. This Research Infrastructure is the world’s largest archive of such pathogens and is set up to respond to outbreaks quickly.

Research Headlines – Collecting the world’s viruses, empowering urgent research

Ebola, Zika, MERS, COVID-19? An EU-funded collection of mammalian viruses is supporting researchers around the globe in their efforts to shed new light on old and emerging illnesses and advance their treatment and control. This Research Infrastructure is the world’s largest archive of such pathogens and is set up to respond to outbreaks quickly.

Research Headlines – Collecting the world’s viruses, empowering urgent research

Ebola, Zika, MERS, COVID-19? An EU-funded collection of mammalian viruses is supporting researchers around the globe in their efforts to shed new light on old and emerging illnesses and advance their treatment and control. This Research Infrastructure is the world’s largest archive of such pathogens and is set up to respond to outbreaks quickly.

How should pharma approach patient collaboration in the 2020s?

From the growing range of patient entities through to new possibilities stemming from technology and patient-generated data, pharma has more and more ways to innovate when it comes to collaborating with patients. 
   Now pharma needs to identify the ones that will really move the dial. “Clearly there is a shift from patient engagement …

How should pharma approach patient collaboration in the 2020s? Read More »

Leading the hunt for a COVID-19 vaccine

  Paul Stoffels, J&J’s Chief Scientific Officer, has given delegates at eyeforpharma’s Barcelona Virtual conference exclusive insights into its rapid progress in the search for a vaccine to the COVID-19 virus.   Speaking to Reuters News on day two of the five-day conference, Stoffels said J&J’s potential vaccine, which has just been chosen as a …

Leading the hunt for a COVID-19 vaccine Read More »

What to Eat and Avoid for Women with BRCA Gene Mutations

Five studies have been performed on breast cancer survival and soy foods involving more than 10,000 breast cancer patients, and together they found that those who eat more soy live longer and have a lower risk of the cancer coming back. What about women who carry breast cancer genes? Fewer than 10 percent of breast …

What to Eat and Avoid for Women with BRCA Gene Mutations Read More »

Patients and RWE: Is this the year?

The long-hyped redefinition of healthcare through wearable tech has been… well, long hyped. Early projects, such as Apple HealthKit and Fitbit, were undoubtably important in redefining ‘the possible’ but they haven’t yet achieved transformative application.    Much has been written on why the philosophy that has driven the astonishing success of consumer technology doesn’t translate …

Patients and RWE: Is this the year? Read More »

Career as Regulatory Specialist MSR Coordination Senior at GSK India

Career as Regulatory Specialist MSR Coordination Senior at GSK India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 5000+ people. Globally, we are a £ 27.4 billion, leading, research-based healthcare and pharmaceutical company. In India, we are one of the market leaders. Post : Regulatory Specialist MSR Coordination …

Career as Regulatory Specialist MSR Coordination Senior at GSK India Read More »

A Renewed Commitment to Our Nation’s Older Adults

The law reauthorizes critical Older Americans Act (OAA) programs through 2024. Since 1965, the OAA has provided critical services that have enabled millions of older Americans to stay in their own homes and communities.  Services supported by the OAA include congregate and home-delivered meals, case management, specialized transportation services, employment and volunteer programs, adult day …

A Renewed Commitment to Our Nation’s Older Adults Read More »

10 ways to avoid corona – Corona Virus Tips

10 ways to avoid corona – Corona Virus Tips: Countries around the world are monitoring the outbreak of Coronovirus Disease 2019 (COVID-19) and are suggesting ways to avoid it. Several things are being told to flow from the corona, which can prevent it from spreading.Today we are telling you about the same coronavirus tips. Carefully …

10 ways to avoid corona – Corona Virus Tips Read More »

Drug repurposing patent documents vs peer review: patent information comes more than 600 days earlier on average

This article was originally published by Hermann Mucke & Peter Mucke in Future Drug Discovery under a Attribution-NonCommercial-NoDerivatives 4.0 Unported License. https://doi.org/10.4155/fdd-2020-0001. Drug developers require access to scientific information in… The post Drug repurposing patent documents vs peer review: patent information comes more than 600 days earlier on average appeared first on DrugPatentWatch – Make …

Drug repurposing patent documents vs peer review: patent information comes more than 600 days earlier on average Read More »

Dr.Reddy’s – Openings for Freshers and Experienced Any Graduates || Any Graduates

Dr.Reddy’s – Openings for Freshers and Experienced Any Graduates || Any Graduates Dear All, If your profile is suitable for Pharma sales job, please share atrupaattal@drreddys.com Also share with your friends and network. Hiring PSR (Professional Service Representative): Education: Any graduate or post graduate. Should have provisional certificate and no backlogs Age limit: 29 years Max Experience: minimum 1 …

Dr.Reddy’s – Openings for Freshers and Experienced Any Graduates || Any Graduates Read More »

Troikaa Pharmaceuticals Urgent Openings in QC | QA | F and D | Production | RA | Warehouse | Engineering and Maintenance | Internal Audit | Finance and Accounts | Marketing | Sales and Admin | International Business apply now

Troikaa Pharmaceuticals Urgent Openings in QC | QA | F and D | Production | RA | Warehouse | Engineering and Maintenance | Internal Audit | Finance and Accounts | Marketing | Sales and Admin | International Business apply now Visit above links for more information

USV Pvt Ltd Hiring For Assistant Manager Plant Training

USV Pvt Ltd Hiring For Assistant Manager Plant Training USV Pvt Ltd Hiring B.Pharm,M.Pharm . We are a leading health care company with the following areas of focus: Branded Generics, Active Pharmaceutical Ingredients (APIs & Formulation) and Bio-similars. Sixty-eight percent of our business is contributed by the India operations and the rest by export of …

USV Pvt Ltd Hiring For Assistant Manager Plant Training Read More »

Syngene International Looking For Bbrc-analytical Research and Development Department

Syngene International Looking For Bbrc-analytical Research and Development Department Syngene International Hiring Any Graduate . Syngene International Limited Incorporated in the year 1994, Syngene International is one of India¢¢s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation …

Syngene International Looking For Bbrc-analytical Research and Development Department Read More »

Zee Laboratries looking for Dispatch Executive apply now

Zee Laboratries looking for Dispatch Executive apply now Zee Laboratories Hiring Any Graduate . Zee Established in the year 1994, at Karnal,Haryana (India), we, Zee Laboratories an WHO-GMP, CGMP and ISO 9001:2000 certified organization are engaged in manufacturing, exporting and supplying a diverse array of Pharmaceutical Medicines… Interested and eligible candidates apply online with link …

Zee Laboratries looking for Dispatch Executive apply now Read More »

Alembic Pharmaceuticals Looking For Executive / Senior Executive API – QC Reviewer

Alembic Pharmaceuticals Looking For Executive / Senior Executive API-QcRm Reviewer Alembic Pharmaceuticals Hiring B.Pharm,M.Pharm.M.sc. Alembic Pharmaceuticals Limited, with an established presence in the Indian pharma industry has a proud, historical track record going back one hundred years. With a turnover in excess of Rs. 3000 crores today, Alembic Pharmaceuticals Limited is one of the leading …

Alembic Pharmaceuticals Looking For Executive / Senior Executive API – QC Reviewer Read More »

Dr. Reddys Laboratories Hiring For Business Analyst

Dr. Reddys Laboratories Hiring For Business Analyst Dr. Reddys Laboratories Hiring B.Tech. Dr. Reddy Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products . Interested and eligible candidates apply online …

Dr. Reddys Laboratories Hiring For Business Analyst Read More »

Bayer Zydus Pharma Hiring for Area Business Manager apply now

Bayer Zydus Pharma Hiring for Area Business Manager apply now Bayer Zydus Pharma Hiring B.Pharma,B.Sc .Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. The Pharmaceuticals Division of Bayer focuses on prescription products for womens healthcare, cardiology, oncology, hematology and ophthalmology. The division also comprises the …

Bayer Zydus Pharma Hiring for Area Business Manager apply now Read More »

Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy

Annals of Pharmacotherapy, Volume 54, Issue 10, Page 1001-1009, October 2020. Objective:To review the efficacy and safety of onasemnogene abeparvovec-xioi (Zolgensma) in the treatment of spinal muscular atrophy (SMA).Data Sources:An English-language literature search of PubMed, MEDLINE, and Ovid (1946 to December 2019) was completed using the terms onasemnogene, AVXS-101, and spinal muscular atrophy. Manufacturer prescribing …

Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy Read More »

Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy

Annals of Pharmacotherapy, Ahead of Print. Objective: To review the efficacy and safety of onasemnogene abeparvovec-xioi (Zolgensma) in the treatment of spinal muscular atrophy (SMA). Data Sources: An English-language literature search of PubMed, MEDLINE, and Ovid (1946 to December 2019) was completed using the terms onasemnogene, AVXS-101, and spinal muscular atrophy. Manufacturer prescribing information, article …

Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy Read More »

Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy

Annals of Pharmacotherapy, Ahead of Print. Objective: To review the efficacy and safety of onasemnogene abeparvovec-xioi (Zolgensma) in the treatment of spinal muscular atrophy (SMA). Data Sources: An English-language literature search of PubMed, MEDLINE, and Ovid (1946 to December 2019) was completed using the terms onasemnogene, AVXS-101, and spinal muscular atrophy. Manufacturer prescribing information, article …

Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy Read More »

Urgent vacancy at Mankind

Urgent vacancy at Mankind *Vacancy*of Medical Representative in *Mankind Pharma Ltd*Div-Future (cardiometabolic ) At *HQ- BHOPAL* Qualification-Graduate/D.PharmaExperienced person will be preferred (6month to 1year Experienced & Age limit -27Years)Contact-Durgesh JaiswalMob.No – *9993498485* Visit above links for more information

Siro Clinpharm Recruiting For Clinical Database Programmer/ Developer

Siro Clinpharm Recruiting For Clinical Database Programmer/ Developer Siro Clinpharm Hiring B.Sc.M.sc .SIRO Clinpharm Private Limited is a Clinical Research Organisation supporting trials from Phase II to Phase IV and beyond post-launch of products. SIRO offers a range of services, from clinical operations to data services, data analytics and medical writing in compliance with international …

Siro Clinpharm Recruiting For Clinical Database Programmer/ Developer Read More »

Coronavirus: 5 Ways You Can Use Social Media and Digital Marketing to Help the Public During the COVID-19 Pandemic

Today I am going to share some important ways that doctors, hospitals and healthcare marketers can use social media to inform the public during the COVID-19 crisis. Priority One: Use social media to convince people to comply with social distancing, and consequently help us all, “flatten the curve!” The US Surgeon General, Dr. Jerome Adams, …

Coronavirus: 5 Ways You Can Use Social Media and Digital Marketing to Help the Public During the COVID-19 Pandemic Read More »

Otsuka Pharmaceutical Recruitment for Officer Micro-QC

Otsuka Pharmaceutical Recruitment for Officer Micro-QC Otsuka Pharmaceutical Hiring B.Sc.M.sc .Otsuka Pharmaceutical India Private Limited (OPI) is a Joint Venture between Otsuka Pharmaceutical Factory, Inc., Japan and Mitsui & Co. Ltd., Japan, India, for Infusion Business in India and Emerging Markets. We primarily manufacture & market products across multiple markets and therapeutic segments. Being a …

Otsuka Pharmaceutical Recruitment for Officer Micro-QC Read More »

Macleods Pharmaceuticals Hiring For Clinical Trial – Medical Doctor

Macleods Pharmaceuticals Hiring For Clinical Trial – Medical Doctor Macleods Pharmaceuticals Hiring MBBS .Macleods, India¢¢s Fastest growing pharmaceutical company, with a strong R&D and own Bio-equivalence centre, manufacturing sites approved by USFDA & WHO Geneva, ranked among the top pharmaceutical companies with a strength of more than 10,000 employees, presently operating in more than 50 …

Macleods Pharmaceuticals Hiring For Clinical Trial – Medical Doctor Read More »

Harman Finochem Recruiting For Technician in Production Department For OSD

Harman Finochem Recruiting For Technician in Production Department For OSD Harman Finochem Hiring B.Sc .Harman Finochem Limited is a leading India-based Pharmaceutical Company which specializes in the manufacture and export of more than 45 Active Pharmaceutical Ingredients (APls) of which 10 are Essential Drugs as per the WHO Model List. Now entering into formulation business…Interested …

Harman Finochem Recruiting For Technician in Production Department For OSD Read More »

Charak Pharma Looking for Product Manager

Charak Pharma Looking for Product Manager Charak Pharma Hiring B.Sc .Charak began in the year 1947 with a vision to improve the quality of life by making herbal healthcare available internationally. Our endeavour is to meticulously research and formulate standardized products of the highest quality…Interested and eligible candidates apply online with link provide at bottom …

Charak Pharma Looking for Product Manager Read More »

Walter Bushnell Hiring for Regional Training Manager

Walter Bushnell Hiring for Regional Training Manager Walter Bushnell Hiring B.Pharma,B.Sc .Walter Bushnell is one of India’s most well renowned pharmaceutical companies with a reputation for innovation, dynamism and quality manifest in the trust placed in us by hundreds of thousands of doctors and millions of patients every day. Walter Bushnell has a long and …

Walter Bushnell Hiring for Regional Training Manager Read More »

Unichem Laboratories Recruiting For HR Executive

Unichem Laboratories Recruiting For HR Executive Unichem Laboratories Hiring Any Graduate .Promoted by the late Mr. Amrut Mody, a pioneer of the Indian pharmaceuticals business, Unichem Laboratories has grown to become one of India’s most respected pharmaceutical companies. It is committed to deliver better health through superior products. By combining strategic research and in-depth industry …

Unichem Laboratories Recruiting For HR Executive Read More »

Lupin Recruiting For Operator/officer For Mdi/dpi Production/packing

Lupin Recruiting For Operator/officer For Mdi/dpi Production/packing Lupin Hiring B.Pharma. Lupin Limited is one of India’s largest manufacturers of bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and …

Lupin Recruiting For Operator/officer For Mdi/dpi Production/packing Read More »

Biocon Recruiting for Contract Manufacturing Planner

Biocon Recruiting for Contract Manufacturing Planner Biocon Hiring MBA/PGDM. Biocon is Asia’s premier biopharmaceutical company that is driven by the vision to make a difference to global healthcare through improved access to high quality, life-saving biotherapeutics by making them affordable for patients across the world…Interested and eligible candidates apply online with link provide at bottom …

Biocon Recruiting for Contract Manufacturing Planner Read More »

Ipca Laboratories Hiring For Depot Manager

Ipca Laboratories Hiring For Depot Manager Ipca Laboratories Hiring Any Graduate. Ipca Laboratories A fully integrated pharmaceutical company engaged in the manufacturing, marketing and distribution of Active Pharmaceutical Ingredients, pharmaceutical formulations and medicinal products across the globe…Interested and eligible candidates apply online with link provide at bottom and check eligibility before apply and Eligibility details …

Ipca Laboratories Hiring For Depot Manager Read More »

Sourcing investigational COVID-19 drugs

Are you trying to source investigational COVID-19 drugs? We’ve pulled out all the relevant supply-chain resources at https://www.drugpatentwatch.com/covid-19/ . Let me know what more we can do.. edit: updated url submitted by /u/drugpatentwatch [link] [comments]

Q&A with Peter Piot about COVID-19

At TEDMED’s gathering in Boston, we had the opportunity to interview on stage the world’s top virologist, Peter Piot. In plain English, Peter provided solid scientific knowledge about COVID-19 and how to cope with it. Short answers, clear explanations. Based on that live interview here is a written Q & A supporting the responses to …

Q&A with Peter Piot about COVID-19

Read More »

Patient Marketing: How Doctors Can Attract More Male Patients

Women may outnumber men when it comes to diagnosis of mental and physical conditions, but they are also more likely to seek treatment or take preventative measures than their male counterparts. For several reasons, men will wait until the last possible minute (or avoid altogether) before going to a doctor or specialists to discuss their …

Patient Marketing: How Doctors Can Attract More Male Patients Read More »

Why LTAC Hospitals are often the Right Choice for Critically Ill Patients

<p>Choosing the care path for critically ill patients is essential to achieving optimal outcomes for both patients and providers. For patients, without the right clinical capabilities and surrounding environment in which to recover, they may suffer medical setbacks that impede recovery. For providers, such as hospitals, major penalties (including extensive fines) can be incurred due …

Why LTAC Hospitals are often the Right Choice for Critically Ill Patients Read More »

Association Between Antipsychotics and Osteoporosis Based on Real-World Data

Annals of Pharmacotherapy, Volume 54, Issue 10, Page 988-995, October 2020. Background:Osteoporosis, which is a major public health concern, has been known to reduce health-related quality of life. Some studies have suggested that antipsychotics could perhaps cause osteoporosis by increasing serum prolactin levels. However, the association between antipsychotics and the risk for developing osteoporosis has …

Association Between Antipsychotics and Osteoporosis Based on Real-World Data Read More »

Association Between Antipsychotics and Osteoporosis Based on Real-World Data

Annals of Pharmacotherapy, Ahead of Print. Background: Osteoporosis, which is a major public health concern, has been known to reduce health-related quality of life. Some studies have suggested that antipsychotics could perhaps cause osteoporosis by increasing serum prolactin levels. However, the association between antipsychotics and the risk for developing osteoporosis has been controversial. Objective: The …

Association Between Antipsychotics and Osteoporosis Based on Real-World Data Read More »

Association Between Antipsychotics and Osteoporosis Based on Real-World Data

Annals of Pharmacotherapy, Ahead of Print. Background: Osteoporosis, which is a major public health concern, has been known to reduce health-related quality of life. Some studies have suggested that antipsychotics could perhaps cause osteoporosis by increasing serum prolactin levels. However, the association between antipsychotics and the risk for developing osteoporosis has been controversial. Objective: The …

Association Between Antipsychotics and Osteoporosis Based on Real-World Data Read More »

Website Modernization Continues

Americans can consume and interact with online information anywhere, anytime from any digital communications device.  We have come to expect instant gratification: what we want, when we want it, where we want it and how we want it so we can talk, interact or act immediately. If we, as consumers, don’t immediately find what we …

Website Modernization Continues Read More »

How to protect yourself from crowdfunding scams before you donate

Protect yourself from crowdfunding scams Many people use crowdfunding platforms like GoFundMe to reach out to their social networks to help pay for much-needed medical treatment. Unfortunately, not every crowdfunding campaign is trustworthy.  While crowdfunding can be a useful way to gather donations for people’s medical and emergency life expenses, it’s also a way to …

How to protect yourself from crowdfunding scams before you donate Read More »

Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Annals of Pharmacotherapy, Volume 54, Issue 10, Page 1010-1015, October 2020. Objective:To review the efficacy and safety of niraparib for the treatment of recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer (OC, FTC, and PPC).Data Sources:A literature search via MEDLINE through PubMed from August 2013 to January 2020 was performed using the key terms …

Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Read More »

Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Annals of Pharmacotherapy, Ahead of Print. Objective: To review the efficacy and safety of niraparib for the treatment of recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer (OC, FTC, and PPC). Data Sources: A literature search via MEDLINE through PubMed from August 2013 to January 2020 was performed using the key terms niraparib, PARP …

Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Read More »

Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Annals of Pharmacotherapy, Ahead of Print. Objective: To review the efficacy and safety of niraparib for the treatment of recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer (OC, FTC, and PPC). Data Sources: A literature search via MEDLINE through PubMed from August 2013 to January 2020 was performed using the key terms niraparib, PARP …

Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Read More »

Iron Sucrose Injection Manufacturer India | Systacare Remedies

Systacare Remedies is a reputed Iron Sucrose Injection Manufacturer in India {WOOFEV IV}. Woofer IV is a dark brown, non-transparent, aqueous solution that is used for the treatment of iron deficiency in the following indications: Where there is a clinical need for a rapid iron supply, In patients who cannot tolerate oral iron therapy or …

Iron Sucrose Injection Manufacturer India | Systacare Remedies Read More »

Evolving HTA frameworks to accelerate innovation

Innovation in the cancer treatment space offers great promise, but even when approved by the European Medicines Agency (EMA) and other national regulatory bodies, patients can still face protracted delays in accessing new treatments.    Uncertainties in the evidence base for pioneering therapies can lead to delays from health technology assessment (HTA) agencies and payers …

Evolving HTA frameworks to accelerate innovation Read More »

Advancing through partnerships

  If any reminder were needed of the power of collaboration in healthcare, it is the global efforts underway to stem the current coronavirus outbreak and to develop treatments for it.   Chris Round, Merck’s Head of International Operations & Global Core Franchises, speaking to eyeforpharma ahead of his eyeforpharma Barcelona Conference 2020 keynote, mentions …

Advancing through partnerships Read More »

The Mindset Membership: Tips to Lose Weight AND Save Money

The Mindset Membership is the monthly companion to Beachbody’s premium nutrition program, 2B Mindset, and part of Nutrition+, our comprehensive solution to help you stay on track and reach your goals. Learn more about Nutrition+ and The Mindset Membership. As a registered dietitian nutritionist, part of my job is to educate my clients about health and …

The Mindset Membership: Tips to Lose Weight AND Save Money Read More »

Building an innovation culture

Anyone pushing the frontiers of innovation has to accept that failure is a part of the process. This should not be a novel concept for pharma, yet in some ways it still is.   Pharmaceutical businesses are good at it in some domains but not others, says Sebastian Guth, President, Americas Region, Bayer. “As a …

Building an innovation culture Read More »

5 things to know about tax Form 1095-A

If anyone in your household had Marketplace health insurance in 2019, you should have already received Form 1095-A, Health Insurance Marketplace Statement, in the mail. Here are 5 important things to know about this form.

Research Headlines – COVID-19: the EU is ready to respond

Across the EU, many people are worried about the novel coronavirus and its rapid spread. The EU project PREPARE, which began in 2014, is responding to COVID-19 by rapidly assessing Europe’s preparedness and deploying vital clinical research.

Research Headlines – COVID-19: the EU is ready to respond

Across the EU, many people are worried about the novel coronavirus and its rapid spread. The EU project PREPARE, which began in 2014, is responding to COVID-19 by rapidly assessing Europe’s preparedness and deploying vital clinical research.

Research Headlines – COVID-19: the EU is ready to respond

Across the EU, many people are worried about the novel coronavirus and its rapid spread. The EU project PREPARE, which began in 2014, is responding to COVID-19 by rapidly assessing Europe’s preparedness and deploying vital clinical research.

Research Headlines – COVID-19: the EU is ready to respond

Across the EU, many people are worried about the novel coronavirus and its rapid spread. The EU project PREPARE, which began in 2014, is responding to COVID-19 by rapidly assessing Europe’s preparedness and deploying vital clinical research.

Research Headlines – COVID-19: the EU is ready to respond

Across the EU, many people are worried about the novel coronavirus and its rapid spread. The EU project PREPARE, which began in 2014, is responding to COVID-19 by rapidly assessing Europe’s preparedness and deploying vital clinical research.

Research Headlines – COVID-19: the EU is ready to respond

Across the EU, many people are worried about the novel coronavirus and its rapid spread. The EU project PREPARE, which began in 2014, is responding to COVID-19 by rapidly assessing Europe’s preparedness and deploying vital clinical research.

The Monthly Fix: How to Kick Your Cravings to the Curb

The Monthly Fix is the monthly companion to Beachbody’s premium nutrition program, Ultimate Portion Fix, created by Super Trainer Autumn Calabrese. Learn more about The Monthly Fix. Cravings. We all get them — that sudden urge to dive headfirst into a bag of salty chips or a plate of sweet, sweet cupcakes. With frosting. And …

The Monthly Fix: How to Kick Your Cravings to the Curb Read More »

Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed

Annals of Pharmacotherapy, Volume 54, Issue 10, Page 975-980, October 2020. Background:Although direct oral anticoagulants (DOACs) carry a lower bleeding risk compared with warfarin, gastrointestinal bleeds (GIB) are a known complication. There are limited data observing outcomes associated with resuming DOACs following a GIB.Objective:The purpose of this study was to evaluate practice patterns and clinical …

Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed Read More »

Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed

Annals of Pharmacotherapy, Ahead of Print. Background: Although direct oral anticoagulants (DOACs) carry a lower bleeding risk compared with warfarin, gastrointestinal bleeds (GIB) are a known complication. There are limited data observing outcomes associated with resuming DOACs following a GIB. Objective: The purpose of this study was to evaluate practice patterns and clinical outcomes of …

Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed Read More »

Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed

Annals of Pharmacotherapy, Ahead of Print. Background: Although direct oral anticoagulants (DOACs) carry a lower bleeding risk compared with warfarin, gastrointestinal bleeds (GIB) are a known complication. There are limited data observing outcomes associated with resuming DOACs following a GIB. Objective: The purpose of this study was to evaluate practice patterns and clinical outcomes of …

Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed Read More »

3 things to know about coronavirus disease and your Marketplace coverage

{% box %} Coronavirus.gov is the source for the latest information about COVID-19 prevention, symptoms, and answers to common questions. USA.gov has the latest information about what the U.S. Government is doing in response to COVID-19. {% endbox %} You may be hearing about the coronavirus (officially called 2019-novel coronavirus or COVID-19) in the news. …

3 things to know about coronavirus disease and your Marketplace coverage Read More »

Advancing Laboratory Diagnostic Stewardship for Healthcare-Associated Infections (HAIs), Antibiotic Resistance, and Sepsis

Emily Curren DVM, MPH On December 9, 2019, CDC’s Division of Healthcare Quality Promotion (DHQP) hosted a meeting at CDC headquarters in Atlanta, Georgia, on improving patient safety through diagnostic stewardship. Meeting attendees represented academia; federal partners; and professional, industry, and patient representative organizations. The meeting focused on identifying emerging issues in the field of …

Advancing Laboratory Diagnostic Stewardship for Healthcare-Associated Infections (HAIs), Antibiotic Resistance, and Sepsis Read More »

Research Headlines – Turning the tide for blue infrastructure

How do you feel after a day at the beach? Energised, centred, relaxed? You are not the only one – it seems that any body of water can potentially boost people’s well-being. EU-funded researchers are studying the health benefits of blue infrastructure to help planners make informed decisions.

Empowering Research Participants with Information

As a pediatric critical care specialist, I witnessed the impact novel treatments could have on the most vulnerable patients; they were often life-saving. None of these medical advances would be possible without people willing to volunteer to participate in medical research. In just over 100 years, Americans’ lifespan has increased by more than 32 years; …

Empowering Research Participants with Information Read More »

Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials

Annals of Pharmacotherapy, Volume 54, Issue 10, Page 949-957, October 2020. Background:The best way to administer steroids for sudden sensorineural hearing loss (SSHL) is still unclear. The present study was aimed at estimating the efficacy of steroids by intratympanic, systemic, and combined therapy (CT) routes.Methods:A systematic literature search was performed from 1950 to October 2019 …

Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials Read More »

Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials

Annals of Pharmacotherapy, Ahead of Print. Background: The best way to administer steroids for sudden sensorineural hearing loss (SSHL) is still unclear. The present study was aimed at estimating the efficacy of steroids by intratympanic, systemic, and combined therapy (CT) routes. Methods: A systematic literature search was performed from 1950 to October 2019 for randomized …

Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials Read More »

Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials

Annals of Pharmacotherapy, Ahead of Print. Background: The best way to administer steroids for sudden sensorineural hearing loss (SSHL) is still unclear. The present study was aimed at estimating the efficacy of steroids by intratympanic, systemic, and combined therapy (CT) routes. Methods: A systematic literature search was performed from 1950 to October 2019 for randomized …

Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials Read More »

Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 872-878, September 2020. Objective: To review phase II and III clinical trial data to evaluate the efficacy and safety of the halobetasol propionate/tazarotene (HP/TAZ) combination lotion (Duobrii), a medication approved by the Food and Drug Administration in April 2019 for adults with plaque psoriasis. Data Sources: A …

Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials Read More »

Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials

Annals of Pharmacotherapy, Ahead of Print. Objective: To review phase II and III clinical trial data to evaluate the efficacy and safety of the halobetasol propionate/tazarotene (HP/TAZ) combination lotion (Duobrii), a medication approved by the Food and Drug Administration in April 2019 for adults with plaque psoriasis. Data Sources: A systematic search (January 2005 to …

Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials Read More »

Looking Back at US Pharmacy’s Past to Help Discern Its Future

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 907-920, September 2020. Objective: To review specific literature that aimed to predict the future of US pharmacy, beginning in the late 1980s. Data Sources: Articles were identified from searching MEDLINE, CINAHL, Google Scholar, and references of relevant articles. The following combinations of search terms were used: future, …

Looking Back at US Pharmacy’s Past to Help Discern Its Future Read More »

Looking Back at US Pharmacy’s Past to Help Discern Its Future

Annals of Pharmacotherapy, Ahead of Print. Objective: To review specific literature that aimed to predict the future of US pharmacy, beginning in the late 1980s. Data Sources: Articles were identified from searching MEDLINE, CINAHL, Google Scholar, and references of relevant articles. The following combinations of search terms were used: future, pharmacy, prediction, and forecast. Study …

Looking Back at US Pharmacy’s Past to Help Discern Its Future Read More »

To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 899-906, September 2020. Objective: To review and evaluate neuromuscular blocking agents (NMBAs) in critically ill patients with acute respiratory distress syndrome (ARDS). Data Sources: A literature search utilizing PubMed was performed (January 1991 to January 2020) using the following search terms: (neuromuscular blocking agents OR neuromuscular blockade …

To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome Read More »

To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome

Annals of Pharmacotherapy, Ahead of Print. Objective: To review and evaluate neuromuscular blocking agents (NMBAs) in critically ill patients with acute respiratory distress syndrome (ARDS). Data Sources: A literature search utilizing PubMed was performed (January 1991 to January 2020) using the following search terms: (neuromuscular blocking agents OR neuromuscular blockade OR cisatracurium OR rocuronium OR …

To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome Read More »

Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 852-857, September 2020. Background: Sulfamethoxazole-trimethoprim (SXT) therapy is commonly used in HIV-infected patients and is associated with hyperkalemia and elevated serum creatinine (SCr). Objective: The purpose of this study was to examine the frequency of hyperkalemia and elevated SCr in hospitalized, HIV-infected patients receiving SXT. Methods: This …

Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim Read More »

Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim

Annals of Pharmacotherapy, Ahead of Print. Background: Sulfamethoxazole-trimethoprim (SXT) therapy is commonly used in HIV-infected patients and is associated with hyperkalemia and elevated serum creatinine (SCr). Objective: The purpose of this study was to examine the frequency of hyperkalemia and elevated SCr in hospitalized, HIV-infected patients receiving SXT. Methods: This was a retrospective, single-center cohort …

Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim Read More »

Tips for “reconciling” your premium tax credit on 2019 taxes

You have until April 15, 2020 to file your 2019 federal income tax return. If you had a Marketplace plan in 2019 and used advance payments of the premium tax credit (APTC) to lower your monthly payment, you’ll have to “reconcile” your tax return.

Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) “Tune Up” Clinic

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 858-865, September 2020. Background: Previous studies show patients with type 2 diabetes (T2D) and a mental health (MH) disorder exhibit poorer glycemic control compared with those without. Objective: Compare mean change in glycosylated hemoglobin (A1C) after 6 months in the Diabetes Intense Medical Management (DIMM) “Tune Up” …

Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) “Tune Up” Clinic Read More »

Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) “Tune Up” Clinic

Annals of Pharmacotherapy, Ahead of Print. Background: Previous studies show patients with type 2 diabetes (T2D) and a mental health (MH) disorder exhibit poorer glycemic control compared with those without. Objective: Compare mean change in glycosylated hemoglobin (A1C) after 6 months in the Diabetes Intense Medical Management (DIMM) “Tune Up” Clinic in patients with and …

Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) “Tune Up” Clinic Read More »

The Best discount online pharmacy

The first online pharmacy (http://rxlegal-online.com) which offers the easiest way of placing order, the fastest shipping to any place on the globe and the cheapest prices on the web. Great deals and free shipping for orders over $200! submitted by /u/Trevor-Mc [link] [comments]

IMPROOF Workshop – 16th Global Congress on Process Safety – 16 August 2020, Houston, TX, USA

IMPROOF is a European Union Horizon 2020 project, which aims to improve the energy efficiency of steam cracking furnaces while reducing emissions of greenhouse gases and NOx. This workshop is organized by the IMPROOF consortium, registration is open for all stakeholders from both industry and academia. There will be a free workshop to share the …

IMPROOF Workshop – 16th Global Congress on Process Safety – 16 August 2020, Houston, TX, USA Read More »

Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 879-898, September 2020. Objectives: To discuss (1) recent and emerging data for pharmacological management of untreated and relapsed/refractory (R/R) mantle cell lymphoma (MCL) with agents approved in the United States, (2) important considerations for toxicity monitoring and management, and (3) preliminary data and ongoing studies for agents …

Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents Read More »

Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents

Annals of Pharmacotherapy, Ahead of Print. Objectives: To discuss (1) recent and emerging data for pharmacological management of untreated and relapsed/refractory (R/R) mantle cell lymphoma (MCL) with agents approved in the United States, (2) important considerations for toxicity monitoring and management, and (3) preliminary data and ongoing studies for agents in MCL-specific clinical trials. Data …

Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents Read More »

TEDMED 2020 Meetups

TEDMED Meetups, uniquely designed conversations, engage the entire TEDMED community to share their individual perspectives and voices to help improve humanity’s health. Read on to view some of the details of these captivating conversations taking place at TEDMED 2020. Meetup 1 Tuesday, March 3rd, 8:00 am- 8:45 am Climate and Culture, A Health Equity Conversation …

TEDMED 2020 Meetups Read More »

Standardized Volume Dosing Protocol of 23.4% Hypertonic Saline for Pediatric Critical Care: Initial Experience

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 866-871, September 2020. Background: Standardized volume dosing of 23.4% hypertonic saline (HTS) exists for adults, but the concentration, dosing and administration of HTS in pediatrics is variable. With emerging pediatric experience of 23.4% HTS, a standard volume dose approach may be helpful. Objective: To describe initial experience …

Standardized Volume Dosing Protocol of 23.4% Hypertonic Saline for Pediatric Critical Care: Initial Experience Read More »

Standardized Volume Dosing Protocol of 23.4% Hypertonic Saline for Pediatric Critical Care: Initial Experience

Annals of Pharmacotherapy, Ahead of Print. Background: Standardized volume dosing of 23.4% hypertonic saline (HTS) exists for adults, but the concentration, dosing and administration of HTS in pediatrics is variable. With emerging pediatric experience of 23.4% HTS, a standard volume dose approach may be helpful. Objective: To describe initial experience with a standardized 23.4% HTS …

Standardized Volume Dosing Protocol of 23.4% Hypertonic Saline for Pediatric Critical Care: Initial Experience Read More »

Customer Success: DrugPatentWatch for Your Library

One of our clients, the Belarus Republican Scientific and Technical Library recently posted an article on how they support innovation. They open with the statement that “The novelty, effectiveness and… The post Customer Success: DrugPatentWatch for Your Library appeared first on DrugPatentWatch – Make Better Decisions.

The Revised Starling Equation: The Debate of Albumin Versus Crystalloids Continues

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 921-927, September 2020. Objectives: The purpose of this critical narrative review is to discuss the revised Starling equation for microvascular fluid exchange and the associated implications for intravenous fluid administration. Data Sources: PubMed (1946 to December 2019) and EMBASE (1947 to December 2019) were used, and bibliographies …

The Revised Starling Equation: The Debate of Albumin Versus Crystalloids Continues Read More »

The Revised Starling Equation: The Debate of Albumin Versus Crystalloids Continues

Annals of Pharmacotherapy, Ahead of Print. Objectives: The purpose of this critical narrative review is to discuss the revised Starling equation for microvascular fluid exchange and the associated implications for intravenous fluid administration. Data Sources: PubMed (1946 to December 2019) and EMBASE (1947 to December 2019) were used, and bibliographies of retrieved articles were searched …

The Revised Starling Equation: The Debate of Albumin Versus Crystalloids Continues Read More »

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that …

Tips for Managing Chronic Pain Beyond Prescription Painkillers Read More »

TEDMED 2020 Hive Innovator Happenings

There are plenty of ways to engage with our TEDMED 2020 class of Hive Innovators. Whether in a Hive Innovator Meetup, the Community Lunch, where we will have the opportunity to explore the Innovator’s “What If” questions, or through TEDMED Scout: Your AR Guide to Innovation. This year, the Hive Innovator experience is powered by our partner TBWAWorldHealth. …

TEDMED 2020 Hive Innovator Happenings Read More »

Extravasation of Noncytotoxic Drugs

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 804-814, August 2020. Objective: Commonly used drugs may be dangerous in case of extravasation. The lack of information from health care teams can lead to delays in both diagnosis and treatments. This review aims at alerting health care professionals about drugs and risk factors for extravasation and …

Extravasation of Noncytotoxic Drugs Read More »

Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 780-787, August 2020. Objective: To review the safety, efficacy, and administration of intranasal (IN) glucagon for the management of hypoglycemia. Data Source: A literature search of PubMed/MEDLINE (1995 to November 2019) using the terms intranasal glucagon, nasal glucagon, glucagon, hypoglycemia treatment, and hypoglycemia management was completed. Study …

Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies Read More »

Current System of Overseeing Drug Trials in Developing Countries by the FDA Is Dangerous

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 928-932, September 2020. Clinical research used to substantiate Food and Drug Administration (FDA) drug approval is increasingly being conducted overseas. One of the enticements to move overseas is unequal oversight by the FDA, and these differences can result in poor quality research and human subject risk. Downstream, …

Current System of Overseeing Drug Trials in Developing Countries by the FDA Is Dangerous Read More »

Current System of Overseeing Drug Trials in Developing Countries by the FDA Is Dangerous

Annals of Pharmacotherapy, Ahead of Print. Clinical research used to substantiate Food and Drug Administration (FDA) drug approval is increasingly being conducted overseas. One of the enticements to move overseas is unequal oversight by the FDA, and these differences can result in poor quality research and human subject risk. Downstream, patients, clinicians, and payers of …

Current System of Overseeing Drug Trials in Developing Countries by the FDA Is Dangerous Read More »

Real-World Evaluation of Dosing in Patients Converted From Insulin Glargine (Lantus) to Insulin Glargine (Basaglar)

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 846-851, September 2020. Background: Basaglar, insulin glargine (BGlar; Eli Lilly, Indianapolis, IN), a follow-on biologic, was developed after the patent for Lantus, insulin glargine (LGlar; Sanofi-Aventis, Paris, France) expired. Objective: To compare the dosing and hemoglobin A1C (A1C)-lowering effects of BGlar compared with LGlar in a real-world …

Real-World Evaluation of Dosing in Patients Converted From Insulin Glargine (Lantus) to Insulin Glargine (Basaglar) Read More »

Real-World Evaluation of Dosing in Patients Converted From Insulin Glargine (Lantus) to Insulin Glargine (Basaglar)

Annals of Pharmacotherapy, Ahead of Print. Background: Basaglar, insulin glargine (BGlar; Eli Lilly, Indianapolis, IN), a follow-on biologic, was developed after the patent for Lantus, insulin glargine (LGlar; Sanofi-Aventis, Paris, France) expired. Objective: To compare the dosing and hemoglobin A1C (A1C)-lowering effects of BGlar compared with LGlar in a real-world setting. Methods: Adult patients, at …

Real-World Evaluation of Dosing in Patients Converted From Insulin Glargine (Lantus) to Insulin Glargine (Basaglar) Read More »

Meet the Session Hosts!

As TEDMED 2020 nears we are excited to announce our 2020 Session Hosts. Playing an integral role at TEDMED, our Session Hosts guide us through our amazing Stage Program, helping to connect the themes and ideas shared by our Speakers throughout the program. In addition to their work on Stage at TEDMED, all of our …

Meet the Session Hosts! Read More »

Calcitonin Gene-Related Peptide Antagonists for the Prevention of Migraine: Highlights From Pivotal Studies and the Clinical Relevance of This New Drug Class

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 795-803, August 2020. Objective: To review the new drug class of calcitonin gene-related peptide antagonists (monoclonal antibodies) and their clinical relevance in migraine prophylaxis. Data Sources: A literature search was performed in PubMed (January 2009 to November 2019) using the terms migraine, calcitonin gene-related peptide (CGRP), erenumab, …

Calcitonin Gene-Related Peptide Antagonists for the Prevention of Migraine: Highlights From Pivotal Studies and the Clinical Relevance of This New Drug Class Read More »

The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex

Annals of Pharmacotherapy, Volume 54, Issue 9, Page 837-845, September 2020. Background: There are limited Australian data on sex differences in oral anticoagulant (OAC) prescribing in atrial fibrillation (AF) and ongoing debate regarding the optimal approach to stroke risk assessment and OAC prescribing in female patients with AF. Objective: The purpose of this study was …

The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex Read More »

The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex

Annals of Pharmacotherapy, Ahead of Print. Background: There are limited Australian data on sex differences in oral anticoagulant (OAC) prescribing in atrial fibrillation (AF) and ongoing debate regarding the optimal approach to stroke risk assessment and OAC prescribing in female patients with AF. Objective: The purpose of this study was to investigate sex differences in …

The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex Read More »

A Review of Deflazacort for Patients With Duchenne Muscular Dystrophy

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 788-794, August 2020. Objective: The objective of this article is to review the pharmacology, pharmacokinetics, efficacy, safety, dosage and administration, and formulary considerations of deflazacort. Data Sources: A search of MEDLINE and EMBASE (1946 to December 31, 2019) was conducted using the terms deflazacort and Duchenne muscular …

A Review of Deflazacort for Patients With Duchenne Muscular Dystrophy Read More »

Research Headlines – Handy mozzie-checking platform to help keep malaria at bay

To spray or not to spray – and potentially, what with: EU-funded researchers are developing a sophisticated system to facilitate analyses of mosquitoes and their mechanisms of resistance to insecticides, support data sharing and refine decision-making processes. Scientists in Cameroon are helping to advance this bid to boost malaria vector control.

Research Headlines – Handy mozzie-checking platform to help keep malaria at bay

To spray or not to spray – and potentially, what with: EU-funded researchers are developing a sophisticated system to facilitate analyses of mosquitoes and their mechanisms of resistance to insecticides, support data sharing and refine decision-making processes. Scientists in Cameroon are helping to advance this bid to boost malaria vector control.

Healthcare Headlines: February 2020

<h2 class="heading-medium">US On Track For One Of The Worst Flu Seasons In Decades </h2> <p>This flu season is on track to be as severe as the deadliest flu season in the United States in more than 40 years. Check out the latest hospitalization rates, year-over-year comparisons and a nationwide map of influenza activity.&nbsp;<a href="https://www.advisory.com/daily-briefing/2020/01/07/flu-update" target="_blank" …

Healthcare Headlines: February 2020 Read More »

Efficacy of Conversion to Aflibercept for Diabetic Macular Edema Previously Refractory to Bevacizumab or Ranibizumab: A Meta-analysis of High-Quality Nonrandomized Studies

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 750-756, August 2020. Background: Aflibercept has been widely used in treating diabetic macular edema (DME). However, the effect of aflibercept in treating DME refractory to bevacizumab or ranibizumab has not been well established. Objective: To assess the therapeutic effect of switching from bevacizumab or ranibizumab to aflibercept …

Efficacy of Conversion to Aflibercept for Diabetic Macular Edema Previously Refractory to Bevacizumab or Ranibizumab: A Meta-analysis of High-Quality Nonrandomized Studies Read More »

TEDMED 2020 Sessions Announced

Inspiring a healthier humanity requires us to push ourselves forward to drive progress while reflecting on the astonishing accomplishments we have achieved. At TEDMED 2020, we will connect with an invisible force that has been propelling humanity forward for millennia—wonder. To experience wonder is to experience the power and possibilities that lay beneath the surface …

TEDMED 2020 Sessions Announced Read More »

GVK Biosciences Walk In for Synthesis R and D /Analytical R and D 1st Feb 2020

GVK Biosciences Walk In  for Synthesis R and D /Analytical R and D 1st Feb 2020 GVK Biosciences Pvt. LtdRecruitment January 2020 M.Sc. Organic Chemistry for Synthesis R&D /Analytical R&D @ Bengaluru.Please go through following summary of vacancy. GVK Biosciences Pvt. Ltd selection as below Full Details Post Name: Synthesis R&D /Analytical R&D Qualification : M.Sc. Organic Chemistry Experience :02 …

GVK Biosciences Walk In for Synthesis R and D /Analytical R and D 1st Feb 2020 Read More »

Amoli Organics Walk In for API Production 2nd Feb 2020

Amoli Organics Walk In for API Production 2nd Feb 2020 Amoli Organics Pvt Ltd Recruitment January 2020 Diploma Chemical / B.Sc / M.Sc / BE Chemical for API Production @ Vapi.Please go through following summary of vacancy. Amoli Organics Pvt Ltd selection as below Full Details Post Name: API Production Qualification : Diploma Chemical / B.Sc / M.Sc / …

Amoli Organics Walk In for API Production 2nd Feb 2020 Read More »

Novartis looking for Scientific Writer | Ph.D, M.Pharm, M.Sc

Novartis looking for Scientific Writer | Ph.D, M.Pharm, M.Sc Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field. Post : Scientific Writer II …

Novartis looking for Scientific Writer | Ph.D, M.Pharm, M.Sc Read More »

Urgent vacancy at Usv ltd

Urgent vacancy at Usv ltd *Vacancy for the Post of MR* *USV* Private Limited *HQ* –  Nagpur Minimum 6 Month Experience. Qualification:- BSc, B Pharm, D Pharm. Interested Candidate Can Call and can Send Resume on following mail id. Vipin RamtekeArea Manager.9673972240.Email id– vipinramteke2007@gmail.com Visit above links for more information

GLAND PHARMA LTD – Walk-In Interviews for Freshers and Experience on 1st Feb’ 2020

GLAND PHARMA LTD – Walk-In Interviews for Freshers and Experience on 1st Feb’ 2020  Greetings from Gland Pharma Limited!! We have urgent Requirement forMicrobiology Department. If you are interested you can walk-in for an interaction on01st February 2020 Between 09.00 AM to 11.00 AM. Job Specification: Experience: 0 to 4 Years Qualification: B.Sc (Microbiology/Biotechnology)/ M Sc (Microbiology/ …

GLAND PHARMA LTD – Walk-In Interviews for Freshers and Experience on 1st Feb’ 2020 Read More »

3 routine ways to use your 2020 Marketplace coverage

Health coverage pays for provider services, prescriptions, hospital care, and special equipment when you’re sick. It’s also important when you’re not sick. Now that you’re enrolled in a health plan for 2020, here’s how you can use your new coverage throughout the year no matter your situation.

Research Headlines – 3D tumour modelling steps up battle against cancer

An EU-funded project is developing innovative ways to mimic the micro-environment that cancer cells encounter inside the human body. The creation of artificial 3D tumour models could pave the way for more accurate testing of cancer drugs and ultimately lead to better treatments.

Achieving Better Health for Mothers and Babies

In our work, we see medical innovation almost daily. The advancements made in neuroscience, bionics and trauma care would be considered miracles to physicians 100 years ago – let alone 10 years ago. Despite many giant leaps forward, our nation continues to struggle with tragic and often preventable deaths related to childbirth. Poor maternal health …

Achieving Better Health for Mothers and Babies Read More »

Urgent Vacancy at IPCA Pharmaceuticals

Urgent Vacancy at IPCA H.Q.INDORE (MR) IPCA LABORATORIES BIONOVA DIVISION POST :  MR ( Med. Rep.)  *H.Q. :-INDORE*  Any Graduate , Age No Bar Min 1 Years  Experiences in Pharma Contact MADAN MOHAN RATHORE MOB:-8602796453 Visit above links for more information

Sanofi Recruitment January 2020 Apply Online Now

Sanofi Recruitment January 2020 B. Sc. Or Preferably B.Pharm for Scientific Sales Ececutive @New Delhi. Please go through following summary of vacancy. Sanofi selection as below Full Details Post Name: Scientific Sales Ececutive Qualification : B. Sc. Or Preferably B.Pharm Experience :2 to 3 years Job Description: We have urgent requirement for the post of …

Sanofi Recruitment January 2020 Apply Online Now Read More »

Dietary Supplements Pose Real Dangers to Patients

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 815-819, August 2020. The Dietary Supplement Health and Education Act led to a flood of poor-quality dietary supplements. The Food and Drug Administration’s (FDA’s) jurisdiction is limited to removing products proven unsafe, rather than prospectively assessing them for quality manufacturing. With so many products available, there is …

Dietary Supplements Pose Real Dangers to Patients Read More »

Impact of an Antimicrobial Stewardship Team on Reducing Antiretroviral Medication Errors

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 767-774, August 2020. Background: Numerous interventions have been used to reduce medication errors related to antiretroviral (ARV) therapy for hospitalized patients with HIV. Objective: This study assessed the impact of an antimicrobial stewardship (ASP) team intervention on reducing the rate of ARV therapy errors in patients admitted …

Impact of an Antimicrobial Stewardship Team on Reducing Antiretroviral Medication Errors Read More »

Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 775-779, August 2020. Background: Subcutaneous trastuzumab (T-SC) administration does not allow the historical target concentration of 20 µg/mL for efficacy to be reached, from the start of treatment in patients with a body mass index (BMI) >30 kg/m2. Objectives: To analyze the influence of the strategy of …

Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients Read More »

Research Headlines – Paving the way to a healthier old age

While lifespans have been steadily increasing, age-related diseases are also on the rise. EU-funded research is looking at ways to help prevent illness in later years and pave the way to a happier and healthier old age.

Research Headlines – Paving the way to a healthier old age

While lifespans have been steadily increasing, age-related diseases are also on the rise. EU-funded research is looking at ways to help prevent illness in later years and pave the way to a happier and healthier old age.

Reflections on the Second Report of the WHO’s NCD Commission

Countries around the world face different and unique public health challenges that sometimes require regional or even international collaboration to solve. One such challenge that has prompted calls for international cooperation are non-communicable diseases, or NCDs for short. Cardiovascular disease, cancer, diabetes, chronic respiratory diseases, and mental health disorders are all examples of NCDs, which …

Reflections on the Second Report of the WHO’s NCD Commission Read More »

Association of Antibiotic Treatment Duration With Recurrence of Uncomplicated Urinary Tract Infection in Pediatric Patients

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 757-766, August 2020. Background: Gaps and inconsistencies in published information about optimal antibiotic treatment duration for uncomplicated urinary tract infection (UTI) in pediatric patients pose a dilemma for antibiotic stewardship. Objective: Evaluate the association of antibiotic treatment duration with recurrence rates in children with new-onset cystitis or …

Association of Antibiotic Treatment Duration With Recurrence of Uncomplicated Urinary Tract Infection in Pediatric Patients Read More »

Associations Between Obesity and the Effectiveness of Anti–Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 729-741, August 2020. Background: A total of 15% to 40% of adult inflammatory bowel disease (IBD) patients are obese. The influence of obesity on anti-tumor necrosis factor-α (anti-TNF-α) treatment in IBD patients is not consistent. Objective: To determine the association between obesity and the efficacy of anti-TNF …

Associations Between Obesity and the Effectiveness of Anti–Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis Read More »

Introducing The Hive 2020!

We are happy to announce the TEDMED 2020 Hive Program, which will feature inspiring entrepreneurs and their organizations. As always, this year’s Hive class is made of Innovators representing early- to mid-stage organizations across 6 categories: 1) Life Sciences & Therapeutics 2) Med-Tech & Med-Device 3) Mobile & Digital Health 4) Health Systems, Care Delivery, …

Introducing The Hive 2020! Read More »

Research Headlines – Sniffing out cancer is as easy as breathing

A team of EU-funded researchers has developed an accurate and non-invasive way to detect cancer through a person’s breath. The hand-held sensor can be used by anyone without medical supervision in combination with their smart phone. Tests reveal the accuracy of the sensor is about 93 %.

Into pharma’s roaring twenties

“I drained the last of my cocktail, gazing up at the ceiling. It was one of those moments that curls the hairs on your neck. At once, the grand scale of this labyrinth of cathedrals became clear, the desert wind blowing through the clever hieroglyphics carved into every available surface. I turned my head back …

Into pharma’s roaring twenties

Read More »

Adrenal Insufficiency and Response to Stress Dose Hydrocortisone in Patients With Cirrhosis and Vasopressor Dependency Using Cirrhosis-Specific Cortisol Thresholds

Annals of Pharmacotherapy, Volume 54, Issue 8, Page 742-749, August 2020. Background: Cortisol thresholds defining adrenal insufficiency (AI) in some cirrhosis-specific studies differ from those recommended by the SCCM/ESICM (Society of Critical Care Medicine/European Society of Intensive Care Medicine) guidelines, which may influence treatment decisions. Objective: To determine if stress-dose hydrocortisone (HC) improves outcomes in …

Adrenal Insufficiency and Response to Stress Dose Hydrocortisone in Patients With Cirrhosis and Vasopressor Dependency Using Cirrhosis-Specific Cortisol Thresholds Read More »

Scaling patient engagement for deeper insights and better outcomes

  There are plenty of reasons to scale patient engagement. It drives a more patient-centric approach, can help create new services and enable better access and approval with payers and regulators.    But perhaps the simplest and most compelling reason for scaling engagement is its link to stronger outcomes, which has a cascade of business …

Scaling patient engagement for deeper insights and better outcomes Read More »

Pharma’s new ally: The caregiver

While pharma and the wider healthcare sector are making patients more central to their innovation efforts these days, little consideration is given to caregivers.   The role of the unpaid caregiver is one they would do well to consider more. Caregivers comprise an enormous, and largely untapped, reservoir of information and wisdom about the individuals …

Pharma’s new ally: The caregiver Read More »

Predicting the Structure of Proteins: Why It Matters

 After water, protein is the next most abundant substance found in the human body. In fact, some experts predict that the human body produces anywhere between 20,000 and 100,000 different types of proteins. That doesn’t include all of the various proteins found in our food sources, biopharmaceuticals, and those produced by other living organisms around …

Predicting the Structure of Proteins: Why It Matters Read More »

The United States Pharmacopeia: 200 Years of Building Trust in Medicine

The TEDMED 2020 theme is Make Way For Wonder, and we are looking forward to convening our Community and embracing the wonders of our times, the astonishing accomplishments, incredible possibilities, and extraordinary potential for the future. So, we were thrilled when the United States Pharmacopeia (USP) decided to celebrate its 200th Anniversary with TEDMED. After …

The United States Pharmacopeia: 200 Years of Building Trust in Medicine Read More »

Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition

Here’s a copy of the recent talk on Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition. It’s based on the book Make Better Decisions, which distills insights… The post Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition appeared first on DrugPatentWatch – Make Better Decisions.

Five Healthcare Trends in 2020: Your Cheat Sheet

<div class="right-align"> <a class="btn btn-blue _gt" data-category="Hospital" data-action="Click-Button" data-label="Blog-Five Healthcare Trends in 2020: Your Cheat Sheet" href="https://www.kindredhealthcare.com/docs/default-source/default-document-library/kindred-hospitals-healthcare-trends-in-2020.pdf?sfvrsn=acbf8dea_2" title="Five Healthcare Trends in 2020: Your Cheat Sheet" target="_blank">Download this article as a PDF</a></div> <br /> <p>In 2020, our nation&rsquo;s healthcare delivery and payment environment will continue its multi-year evolution. While some key trends will continue and expand, …

Five Healthcare Trends in 2020: Your Cheat Sheet Read More »

Advancing RWE together with academia

  The promise of real-world Evidence (RWE) to offer a cost-effective way to help drive transformations in healthcare and drug development is dependent on significant improvements being made in the way real-world data (RWD) is collected and developed into robust evidence.   Challenges include limited access to databases, incomplete data and problems dealing with the …

Advancing RWE together with academia Read More »

Take advantage of free preventive services in 2020

With Marketplace coverage, you have access to free preventive services, like flu shots, check-ups, and screening tests. Getting these recommended services is an important step toward good health and well-being.

Invest in MSLs to reap bigger gains

  If authenticity, data analysis and good customer rapport are the superpowers pharma needs most today, MSLs are the superheroes most able to wield them.   As the MSL’s role continues to evolve from a supporting to a far more strategic one, pharma companies have much to gain from getting the most from this ever …

Invest in MSLs to reap bigger gains Read More »

MorphoSys Reports Submission of Tafasitamab’s BLA to the US FDA to Treat Relapsed or Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL)

Shots: The BLA submission is based on L-MIND P-II trial data results assessing Tafasitamab + lenalidomide in patients with r/r DLBCL and retrospective observational matched control cohort Re-MIND evaluating efficacy outcomes of r/r DLBCL patients who received Tafasitamab + lenalidomide vs lenalidomide monothx Re-MIND has met its 1EPs and has shown improved ORR of the …

MorphoSys Reports Submission of Tafasitamab’s BLA to the US FDA to Treat Relapsed or Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL) Read More »

Clover Reports First Patient Dosing in P-III Trial with SCB-808 (biosimilar, etanercept) in China

Shots: The P-III study involves assessing of SCB-808 (SC) vs Enbrel (SC) in patients with ankylosing spondylitis (radiographic axial spondyloarthritis) to evaluate its safety, efficacy and PK The company utilizes its Trimer-Tag technology platform to develop novel therapies targeting trimerization-dependent pathways and is also leveraging its cGMP biomanufacturing capabilities to develop biosimilars SCB-808 is mAb …

Clover Reports First Patient Dosing in P-III Trial with SCB-808 (biosimilar, etanercept) in China Read More »

GenScript Signs an Agreement with Selecxine to Develop Therapies for Immuno-Oncology

Shots: GenScript will be responsible for all pre-clinical pharmacy research and IND filling in Selecxine’s project which is based on cytokine-antibody complexes The company provided development solutions in different hosts tailored to customers and provided the preparation and purification solutions for the final complex,; further the project will test and enhance the process development capability …

GenScript Signs an Agreement with Selecxine to Develop Therapies for Immuno-Oncology Read More »

Acceleron Signs a License Agreement with Fulcrum for the Identification of Therapies to Treat Pulmonary Diseases

Shots: Fulcrum to receive $10M upfront, reimbursement for R&D costs, research, development and commercial milestone of up to $295M for first product commercialized and additional payments $143.5M for all subsequent products commercialized plus royalties on sales of product Acceleron to get rights to access Fulcrum’s product engine and target identification platform for identifying small molecule …

Acceleron Signs a License Agreement with Fulcrum for the Identification of Therapies to Treat Pulmonary Diseases Read More »

BeiGene’s Tislelizumab Receives NMPA’s Approval for the Treatment of 2L Classical Hodgkin’s Lymphoma (cHL)

Shots: The approval is based on P-II BGB-A317-203 (NCT03209973) trial which involves assessing of tislelizumab with median follow up of 14 months The study resulted in ORR as 76.9% and CR as 61.5% with no fatal adverse reactions. BieGene’s Tislelizumab is the first drug to be approved in China and the candidate’s NDA has also …

BeiGene’s Tislelizumab Receives NMPA’s Approval for the Treatment of 2L Classical Hodgkin’s Lymphoma (cHL) Read More »

Eli Lilly Opens its P-III LIBRETTO-531 Clinical Trial for LOXO-292 (selpercatinib) to Treat RET-Mutant Medullary Thyroid Cancer (MTC) Patients

Shots: The second P-III LIBRETTO-531 involves assessing of selpercatinib vs physician’s choice of cabozantinib or vandetanib in 400 patients in ratio (2:1) with advanced or metastatic RET-mutant MTC who have received no prior systemic therapy for metastatic disease The study will have efficacy endpoints as progression-free survival (PFS), treatment failure-free survival (TFFS), overall survival (OS), …

Eli Lilly Opens its P-III LIBRETTO-531 Clinical Trial for LOXO-292 (selpercatinib) to Treat RET-Mutant Medullary Thyroid Cancer (MTC) Patients Read More »

AstraZeneca and Merck & Co’s Lynparza Receive the US FDA’s Approval as a 1L Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer

Shots: The approval follows the US FDA Oncologic drugs Advisory Committee (ODAC) on 17 Dec based on P-III POLO trial, which involves assessing of Lynparza tablets (300 mg bid) as maintenance monothx vs. PBO in 154 patients in ratio (3:2) with gBRCAm metastatic pancreatic cancer whose disease had not progressed on at least 16 weeks …

AstraZeneca and Merck & Co’s Lynparza Receive the US FDA’s Approval as a 1L Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer Read More »

Zai Lab’s Zejula (niraparib) Receives NMPA’s Approval as Maintenance Therapy for Patients with Recurrent Ovarian Cancer in China

Shots: Zejula (niraparib) is an oral once-daily poly (ADP-ribose) polymerase (PARP) inhibitor used as a maintenance therapy for adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy The NMPA approval of Zejula is novel product approved in Mainland China, has shown 73% …

Zai Lab’s Zejula (niraparib) Receives NMPA’s Approval as Maintenance Therapy for Patients with Recurrent Ovarian Cancer in China Read More »

Eisai Reports Results of DAYVIGO (lemborexant) in P-III SUNRISE 1 Study in Patients with Insomnia Disorder

Shots: The P-III SUNRISE 1 (Study 304) study involves assessing of DAYVIGO (lemborexant, 5 or 10 mg) vs an active comparator or PBO in 1,006 patients with insomnia disorder aged 55 years of age or older Results of P-III study@ 5/10 mg of DAYVIGO: headache (6.4%, 4.9 % vs 6.2%, 5.3%), somnolence (4.1%, 7.1% vs …

Eisai Reports Results of DAYVIGO (lemborexant) in P-III SUNRISE 1 Study in Patients with Insomnia Disorder Read More »

Clover Reports Dosing of SCB-808 (biosimilar, etanercept) in P-III Trial in China

Shots: The P-III study involves assessing of SCB-808 vs Enbrel in patients with AS (axSpA) via SC administration SCB-808 is being developed in the prefilled syringe formulation which is ready for injection and can be self-administered by the patients, thus overwhelming the current Enbrel biosimilar which are available in lyophilized powder formulation in China Clover …

Clover Reports Dosing of SCB-808 (biosimilar, etanercept) in P-III Trial in China Read More »

eyeforpharma Awards: Recognizing and celebrating innovation

At the eyeforpharma Awards we strive to reward, support and incentivise innovation, especially when it comes to the value pharma offers patients and customers. We only recognize meaningful innovation which takes our industry, our reputation and our impact forward and the entries are measured objectively by external judges.   I was amazed by the quality …

eyeforpharma Awards: Recognizing and celebrating innovation Read More »

Now that you’re covered for 2020, don’t forget to pay your premium

Congratulations on your enrollment in a 2020 Marketplace plan! Now that you’re covered, don’t forget to pay your monthly premium to your health insurance company (not the Marketplace) to activate your coverage. Your coverage won’t start until you do.